Clinical Trials in Bedford, Texas

20 recruiting

Showing 119 of 19 trials

Recruiting
Phase 3

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma
Regeneron Pharmaceuticals560 enrolled109 locationsNCT06246916
Recruiting
Phase 3

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab660 enrolled74 locationsNCT07166094
Recruiting
Phase 3

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Infertility (IVF Patients)
Granata Bio Corporation659 enrolled16 locationsNCT07216742
Recruiting
Phase 2

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Hypertension
Novartis Pharmaceuticals380 enrolled84 locationsNCT06857955
Recruiting
Phase 1Phase 2

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Breast CancerBreast Neoplasms
Pfizer100 enrolled166 locationsNCT06966453
Recruiting
Phase 3

Pelacarsen Roll-over Extension Program

Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals599 enrolled97 locationsNCT06875973
Recruiting
Phase 2Phase 3

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Mirati Therapeutics Inc.806 enrolled764 locationsNCT04613596
Recruiting
Phase 3

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 3

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian CancerFallopian Tube CancerPeritoneal Cancer
AbbVie520 enrolled264 locationsNCT05445778
Recruiting

FX Shoulder Prospective Clinical Study

Osteoarthritis ShoulderRotator Cuff Syndrome of Shoulder and Allied DisordersFracture, Shoulder
FX Shoulder Solutions600 enrolled4 locationsNCT06078865
Recruiting
Not Applicable

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

rotator cuff injuries
Smith & Nephew, Inc.234 enrolled20 locationsNCT05444465
Recruiting
Phase 2Phase 3

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Solid Cancer
Daiichi Sankyo860 enrolled120 locationsNCT06161025
Recruiting
Phase 3

Fertilo In Vitro Research Study and Trial

In Vitro Maturation of Oocytes
Gameto, Inc.500 enrolled11 locationsNCT06858111
Recruiting
Phase 2

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

NSCLC
Eikon Therapeutics70 enrolled39 locationsNCT06246110
Recruiting
Phase 3

ZILRETTA in Subjects With Shoulder Osteoarthritis

Glenohumeral Osteoarthritis
Pacira Pharmaceuticals, Inc150 enrolled32 locationsNCT06269705
Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer
Agendia30,000 enrolled134 locationsNCT03053193
Recruiting
Phase 2

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Gastric CancerGastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Toray Industries, Inc146 enrolled27 locationsNCT06038578
Recruiting
Phase 3

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Breast Cancer (Early Breast Cancer)
AstraZeneca5,500 enrolled794 locationsNCT05952557
Recruiting
Not Applicable

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Cervical Cancer
GOG Foundation840 enrolled136 locationsNCT04831580